[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"magnetotherapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:magnetotherapy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,69],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100636341","effects-of-additional-high-intensity-pulsed-electromagnetic-field-hi-pemf-therapy-on-pain-and-physical-function-after-total-hip-replacement-100636341",false,"NCT07564427","Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement","Effects of Additional High-Intensity Pulsed Electromagnetic Field (HI-PEMF) Therapy on Pain and Physical Function After Total Hip Replacement: A Randomized Controlled Trial","Inclusion Criteria:\n\nA. Age 18 years or older.\n\nB. Patients who have undergone primary unilateral total hip arthroplasty due to hip osteoarthritis.\n\nC. Patients who, after postoperative evaluation by their surgeon, are advised to bear full weight within their tolerance.\n\nExclusion Criteria:\n\nA. Patients who have not undergone primary hip arthroplasty.\n\nB. Patients who are advised by their doctor to maintain non-weight-bearing or partial weight-bearing on the affected or unaffected side.\n\nC. History of neurological deficits (e.g., sensory abnormalities, stroke, spinal cord injury, Parkinson's disease, multiple sclerosis).\n\nD. Mini-Mental State Examination (MMSE) \\\u003C 24 (mild cognitive impairment).\n\nE. Berger's Balance Scale (BBS) \\\u003C 40 (higher risk of falls).\n\nF. Sensory abnormalities.\n\nG. Before or after this exercise training, if pain in other areas (e.g., degenerative pain in the knee or spine) prevents movement, or if the hip joint still experiences pain on a Visual Analogue Scale (VAS) score of 4 or higher even after taking pain medication.\n\nH. Known malignancy.\n\nI. Schizophrenia, bipolar disorder, or substance addiction (e.g., alcohol, drug).\n\nJ. Pregnant woman.\n\nK. Individuals with implanted stents, pacemakers, or those requiring treatment for arrhythmia.\n\nL. Wearing a hearing aid.","ALL","18 Years","99 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to verify whether high-intensity pulsed electromagnetic fields (HI-PEMF) can be effectively applied to postoperative total hip arthroplasty patients. Using pain and function as the primary assessment indicators, the study explores the effects of HI-PEMF on postoperative total hip arthroplasty to confirm its effectiveness in relieving pain and improving daily living functions. Simultaneously, it combines physical therapy with exercise training to simulate a clinical environment, comprehensively understanding the feasibility of future clinical applications of magnetic field therapy. It is hoped that by exploring the potential benefits of magnetic field intervention in improving the postoperative condition of these high-needs patients, new clinical evidence can be provided for postoperative management.",[27,28],"Total Hip Arthroplasty (THA)","Magnetotherapy","NOT_YET_RECRUITING","2026-05-10",{"date":32,"type":33},"2026-05-13","ACTUAL",{"date":35,"type":21},"2026-04-28",{"date":37,"type":21},"2027-07-30",{"name":39,"class":40},"National Taiwan University Hospital","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":22,"phases":51,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":68},"100627158","effect-of-magnetotherapy-combined-with-cold-application-and-exercise-in-patients-with-lateral-epicondylitis-100627158","NCT07444996","Effect of Magnetotherapy Combined With Cold Application and Exercise in Patients With Lateral Epicondylitis","Effectiveness of Magnetotherapy in Patients With Lateral Epicondylitis: A Randomized Double-Blind Controlled Trial","MAGNET-LE","Inclusion Criteria:\n\n* Age between 18 and 65 years\n* Clinical diagnosis of lateral epicondylitis\n* Tenderness over the lateral epicondyle on palpation\n* Tenderness over the common extensor tendon\n* At least one positive provocation test (Cozen, Mill's, or Maudsley's test)\n* Willingness to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Acute infection\n* Elbow surgery within the past 12 months\n* Presence of electronic implants (e.g., pacemaker, cochlear implant)\n* Pregnancy\n* Physical therapy for the elbow within the past 3 months\n* Corticosteroid injection to the elbow within the past 3 months\n* History of elbow trauma within the past 3 months\n* Hyperthyroidism or adrenal hyperfunction\n* Paroxysmal neurological disorders (e.g., epilepsy)\n* Myasthenia gravis\n* Inability to comply with the treatment protocol or follow-up assessments","65 Years",{"count":20,"type":21},[24],"This study aims to evaluate the effectiveness of magnetotherapy in the treatment of lateral epicondylitis (tennis elbow). Lateral epicondylitis is a common musculoskeletal condition characterized by pain and tenderness over the outer part of the elbow, often associated with repetitive wrist extension and gripping activities. It may cause reduced grip strength, functional limitations, and decreased quality of life.\n\nIn this prospective, randomized, double-blind, sham-controlled clinical trial, 40 patients aged 18-65 years diagnosed with lateral epicondylitis will be enrolled. Participants will be randomly assigned into two groups using the sealed envelope method.\n\nThe experimental group will receive active magnetotherapy in addition to standard treatment (local application and supervised exercise therapy). The control group will receive sham magnetotherapy (inactive device without magnetic field) plus the same standard treatment. Treatments will be administered five days per week for three weeks.\n\nMagnetotherapy will be applied at a frequency of 50 Hz and intensity of 85 Gauss for 30 minutes per session. All participants will also receive 15 minutes of local application and 15 minutes of supervised exercises including eccentric wrist extensor exercises, isotonic strengthening, stretching, and isometric exercises.\n\nOutcomes will be evaluated at baseline (week 0), at the end of treatment (week 3), and at follow-up (week 12). Primary and secondary outcome measures include pain intensity (Visual Analog Scale), pressure pain threshold (algometer), grip strength (hand dynamometer), functional status (PRTEE and QuickDASH questionnaires), quality of life (SF-36), clinical provocation tests (Cozen, Mill's, and Maudsley's tests), and patient satisfaction (Likert scale).\n\nThe study hypothesis is that adding magnetotherapy to standard treatment will provide additional benefit in reducing pain and improving function compared to standard treatment alone.",[28,54],"Lateral Epicondylitis (Tennis Elbow)",[56,57,58],"magnetotherapy","lateral epicondylitis","tennis elbow","2026-03-05",{"date":61,"type":33},"2026-03-09",{"date":63,"type":21},"2026-02-27",{"date":65,"type":21},"2026-11-27",{"name":67,"class":40},"Fatih Sultan Mehmet Training and Research Hospital",1,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":49,"enrollmentInfo":76,"targetDuration":4,"studyType":22,"phases":78,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":68},"100626463","magnetotherapy-in-carpal-tunnel-syndrome-randomized-controlled-study-100626463","NCT07435961","Magnetotherapy in Carpal Tunnel Syndrome: Randomized Controlled Study","Evaluation of the Effectiveness of Magnetotherapy in Patients With Carpal Tunnel Syndrome: A Placebo-Controlled, Triple-Arm, Randomized, Double-Blind Study","Inclusion Criteria:\n\n* Adults aged between 18 and 65 years.\n\nClinical diagnosis of carpal tunnel syndrome (CTS) based on physical examination findings, including positive Tinel and\u002For Phalen tests and hypoesthesia in the 3rd to 5th digits.\n\nElectrophysiologically confirmed mild-to-moderate carpal tunnel syndrome based on electromyography (EMG) findings.\n\nExclusion Criteria:\n\n* Severe carpal tunnel syndrome confirmed electrophysiologically by electromyography (EMG).\n\nHistory of previous surgical intervention for carpal tunnel syndrome.\n\nPresence of other peripheral nerve entrapments (e.g., ulnar nerve entrapment, radial nerve entrapment).\n\nElectrophysiologically confirmed polyneuropathy or cervical radiculopathy\u002Fcervical discopathy.\n\nRheumatologic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus).\n\nDiabetes mellitus (Type 1 or Type 2).\n\nPregnancy.\n\nPresence of electronic implants such as cardiac pacemaker, cochlear implant, or implantable defibrillator.\n\nActive acute infection.\n\nHistory of malignancy.\n\nReceipt of physical therapy or rehabilitation for the wrist or surrounding area within the past 6 months.\n\nCorticosteroid injection to the wrist within the past 6 months.\n\nHyperthyroidism or adrenal gland hyperfunction.\n\nOpen growth plates (epiphyseal plates not closed).\n\nParoxysmal neurological disorders (e.g., epilepsy).\n\nMyasthenia gravis.\n\nRegular use of pain medications such as pregabalin, duloxetine, or non-steroidal anti-inflammatory drugs (NSAIDs).",{"count":77,"type":21},60,[24],"This study is designed to investigate the effectiveness of low-frequency pulsed electromagnetic field therapy in individuals diagnosed with mild-to-moderate carpal tunnel syndrome (CTS). This double-blind, randomized controlled trial will randomly assign participants into three groups:\n\nGroup 1: Active magnetotherapy\n\nGroup 2: Placebo magnetotherapy (treatment using an identical device that does not generate a magnetic field)\n\nGroup 3: Routine (conservative) treatment group\n\nAll participants will receive a standard nighttime wrist splint and a standardized nerve and tendon gliding exercise protocol. Magnetic field applications will be administered five days per week for a total of 15 sessions. Assessments will be conducted at baseline (T0), at the end of treatment (T1 - Week 3), at 1 month (T2), and at 3 months (T3).\n\nThe primary outcome measures include the Boston Carpal Tunnel Questionnaire (BCTQ), pain intensity assessed by the Visual Analog Scale (VAS), functional status measured by QuickDASH, median nerve cross-sectional area assessed by ultrasonography, sensory function evaluated using the Semmes-Weinstein monofilament test, grip strength measured by dynamometry, and clinical test results (Tinel and Phalen tests). Secondary outcomes include sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI) and patient satisfaction.\n\nThis study aims to contribute to the scientific evidence regarding the effectiveness of magnetotherapy as a non-invasive treatment option for carpal tunnel syndrome.",[28,81,82],"Carpal Tunnel Syndrome (CTS)","Median Nerve Compression",[84,85,56],"median nerve compression","carpal tunnel syndrome(cts)","2026-02-21",{"date":63,"type":33},{"date":89,"type":21},"2026-02-01",{"date":91,"type":21},"2026-11-01",{"name":67,"class":40}]